Page 12 - ரோசாலிண்ட் பிராங்க்ளின் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Permission granted by Johnson & Johnson The Food and Drug Administration on Saturday gave emergency authorization to a coronavirus vaccine developed by Johnson & Johnson, making a third shot available at a critical moment for U.S. efforts to control COVID-19. J&J s vaccine, which requires one dose rather than two and can be stored at refrigerator temperatures, will provide much-needed reinforcements as states across the country expand eligibility for immunization beyond older adults and healthcare workers. Only 3.9 million doses were immediately available to ship, however. McKesson, a drug distributor contracted by the U.S., confirmed first shipments on Monday. J&J expects to deliver 20 million doses by the end of March and 100 million by the end of June, adding to increasing supplies from Pfizer and Moderna, which developed the two other vaccines authorized for use in the U.S.

United statesSouth africaArchana chatterjeeEric rubinJay portnoyJanet woodcockCenters for diseaseDrug administration onChicago medical school at rosalind franklin universityWorld health organizationDrug administrationChicago medical schoolRosalind franklin universityDisease controlSouth americanNew england journal